Kevin S. Boyle Sr. - 30 Aug 2022 Form 4 Insider Report for Alaunos Therapeutics, Inc. (TCRT)

Role
Chief Executive Officer, Director
Signature
/s/ Melinda Lackey, Attorney-in-Fact
Issuer symbol
TCRT
Transactions as of
30 Aug 2022
Net transactions value
-$45,188
Form type
4
Filing time
01 Sep 2022, 16:30:33 UTC
Previous filing
01 Apr 2022
Next filing
17 Mar 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TCRT Common Stock Tax liability $45,188 -18,750 -2.1% $2.41* 866,250 30 Aug 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares withheld by the Issuer to satisfy a portion of the tax withholding obligations in connection with the vesting of shares of restricted stock previously granted to the Reporting Person.